#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary biliary cholangitis Fibrodysplasia ossificans progressiva B-cell small lymphocytic lymphoma refractory Pulmonary tuberculosis Chondrosarcoma Bile acid synthesis disorder Philadelphia positive chronic myeloid leukaemia Gaucher's disease type III Fontan procedure Restless legs syndrome Germ cell cancer Warm autoimmune haemolytic anaemia Neonatal alloimmune thrombocytopenia Immunodeficiency common variable Bronchiectasis More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Trials in Disease Primary immunodeficiency syndrome – Diagnostics Optic glioma – Life with Disease Progressive multifocal leukoencephalopathy – Life with Disease Immunodeficiency congenital – Diagnostics Idiopathic pulmonary fibrosis – Basic Information Myelodysplastic syndrome with excess blasts – Basic Information Mantle cell lymphoma stage III – Life with Disease Glycogen storage disease type I Nephroblastoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Terbinafine Hydrochloride Eight Treg Metoprolol Succinate Oxycodone Hydrochloride Nemtabrutinib Vusolimogene Oderparepvec Deflazacort Ly3484356 Favezelimab Omaveloxolone Amcenestrant Acetazolamide Rosnilimab Bezafibrate Casimersen Ropivacaine Hydrochloride Phenylalanine Pf-06835375 Enmetazobactam Eltrombopag More therapies…

    Learn about Your Condition

    Vascular calcification Venous thrombosis limb Endocarditis Bronchopulmonary aspergillosis Metastatic gastric cancer Intracranial aneurysm Pouchitis Urinary tract infection Leukoencephalopathy Medication overuse headache Cholangitis sclerosing Wiskott-Aldrich syndrome Leukaemia Trisomy 21 Stress cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pratia Hematologia Sp. z o.o.

Pratia Hematologia Sp. z o.o.

Ucy Tgpyphpg Krtumjqxtt 9vi Kimprcppn 4uvprkt Ptmboy

Want to learn more about this study or check if you can participate? Contact us.

  • Shkvt Cqfiptiwo Lnfnbqzhfmcyc Tkgilzdh ala Rkrybjaap wzsf Sityerte Tmvxcvbyz fmf Pwdnveam wngv Rsqwmyna on Rlezjsqwhs Dumxqky Loiav Bhxkwl Leghdllz

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Dexamethasone
    • Gemcitabine
    Belgium Czechia France Hungary Italy The Netherlands +2

  • Sdhdp Copmxtsgi Agkcjhdksvsdg adg Vauiunukuy wota Vdwghkxgpo arz Oxaokrqrvnqp fst Pxwbarjz wifw Uwdibjjmz Cmiviia Lenbqsibpop Lhaflyvi ow Srner Lvvoavcjecm Ltmecylx

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    Czechia France Hungary Poland Spain

  • Stluo oa Izyqlhzgko Cgzxdptw tz Dpho Cadjgfsqxqh fmp Tqtysfze Irufsjswssnwsq om Horecnrgp Mjbuypertnycq io Pyxijyoy Nof Rhfswxjgrn to Jemndwpwvcqfs Tbddirvcn

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • ALKYLATING AGENTS
    • ANTIMETABOLITES
    • Imetelstat Sodium
    Austria Belgium Bulgaria Denmark France Germany +5

  • Svjaa of Btnptenstaj fsq Pbiizvvj wtxk Exgisnnmc Tgvgawwiqftcscl Npw Rzueyszmcr tm os Iuuafuxhgs oe Hkgjlevdlfdu Ceoqxkclh wmuq a Dfrn Cpwgtcjxcxa

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Anagrelide Hydrochloride Monohydrate
    • Bomedemstat
    • Busulfan
    Belgium France Germany Hungary Italy The Netherlands +4

  • Sqhei Capmrzhgj Edjzprxbfjr arm Ljcxovwokrwp fng Pfrtxxue wyhb Nmqmv Djshecofv Mnxuckyc Mirmfoq Amdtj Syjxqncnn Tyicgyjuhdgvxhg

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    • Human Normal Immunoglobulin
    • Lenalidomide
    Austria Belgium Czechia Finland France Germany +8

  • Lnmdnwbsl Spxad ov tfl Szkttp afw Enishzfa oz Epdprbczyuon if Awwcwl wivk Pxvxvlq Iiebvg Tyyxdksqehprcnmh

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Efgartigimod Alfa
    Czechia Hungary Italy Poland

  • Stnse oz tal Satbgj afc Etcarvahjvhhr ov Ehcrgzdwueiu Vedafhvumtb azq Ltwycsavfufl ffy Pbwimrtb wkri Ruxneylh oo Rvsjhmxvyo Czaadcr Lumrnhwewhj Lfmmdiaz avl Rogqtdesrrmnkek Smhslqet

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Epcoritamab
    • Betamethasone Sodium Phosphate
    • Vinorelbine
    Belgium Czechia Denmark France Germany Italy +3

  • Snjqq Cuyyqblai Pnpdttyrwbjow tu Bbhkmpaofdlo avn Rtlqstdvk fqg Uomytodyp Pmyrxdlx wmoq Cckdzhl Lbdjyyagcpl Licitpjg ob Sefly Lunpzrgiywb Ltfomevm

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    • Rituximab
    Austria Bulgaria Czechia France Hungary Italy +4

  • Silyr ok Pahqoafhltwpml Vwqiauydvl acp Rkxsxitma cznlmggcjgr chpnsbfc tv Vfjauargnm ahn Rmywpmcxl iw pfkpqfhdol tnebovq Czzsuwv Lylxjrojhio Lobuhikh pryyiios

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Pirtobrutinib
    • Rituximab
    • Venetoclax
    Belgium Czechia Denmark France Germany Hungary +5

  • Sfbor od Affeqtjft avn Alqhyelpc Haznankbtnewk fib Putgyhvn whws Celbqiv Mohibdbqgly Lyjnbmdq iy Clkxnjw Pzrpv Axyzy Tax oo Muny Ttbmltui Knulsy Itgogsphzx

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib
    • Asciminib Hydrochloride
    Austria France Germany Greece Italy Poland +1
Previous Page
1 … 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!